Transrectal ultrasound in the evaluation of rhabdomyosarcoma involving the prostate

Terris, Martha K.; Eigner, Edward B.; Briggs, E.M.; Reese, Jeffrey; Torti, Frank M.; Freiha, Fuad S.

doi:10.1111/j.1464-410x.1994.tb16624.x

Cited by 7 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The relatively small size of the pre‐pubertal prostate is likely to make TRUS biopsy of the prostate inaccurate and increase morbidity 5, 6. Terris et al 7 used TRUS to evaluate RMS of the prostate in three patients including a 13‐year‐old male, although the biopsies were taken transurethrally. Although open biopsy can be considered in certain anatomical sites, the genitourinary system does not lend itself to this mode of biopsy as the surgical morbidity would be significant.…”

Section: Discussionmentioning

confidence: 99%

Cystoscopy assisted transvesical biopsy of prostatic rhabdomyosarcoma

England

Al-Adnani

Cohen

et al. 2010

Pediatric Blood & Cancer

View full text Add to dashboard Cite

The treatment of prostatic rhabdomyosarcoma (RMS) depends on tumour stratification based on site and histology. An increasing range of cytogenetic, molecular, and immunohistochemistry studies are required. This is difficult to achieve using standard cystoscopic biopsies alone. We present a 5-year-old male, diagnosed with a prostatic RMS. He underwent cystoscopy to confirm the diagnosis and at the same time tissue was obtained for histology using laparoscopic graspers via a STEP Port inserted percutaneously into the apex of his bladder. Histology and cytogenetics confirmed an embryonal botryoid RMS for which he received chemotherapy followed by a radical prostatectomy for residual disease.

show abstract

Section: Discussionmentioning

confidence: 99%